Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04003766 · ClinicalTrials.gov registry record · NA
Endoscopic Ultrasound vs Percutaneous Route for Liver Biopsy
A NA study, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT04003766 is a NA study that has completed, run by AdventHealth. The registered enrollment target is 40 participants.
The verdict
NCT04003766, a NA study, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study is to evaluate and directly compare the technical success, tissue quality, diagnostic efficacy and safety profile of Percutaneous and Endoscopic Ultrasound-guided Liver Biopsy.
Interventions
- DIAGNOSTIC_TEST biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-07-25 |
| Est. Completion | 2022-02-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04003766
The ClinicalTrials.gov registry entry for NCT04003766 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which biopsy is the first listed.
NCT04003766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04003766 about?
NCT04003766 is a clinical study titled "Endoscopic Ultrasound vs Percutaneous Route for Liver Biopsy". This study is to evaluate and directly compare the technical success, tissue quality, diagnostic efficacy and safety profile of Percutaneous and Endoscopic Ultrasound-guided Liver Biopsy.
What is the current status of trial NCT04003766?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-07-25. Estimated completion is 2022-02-11.
What interventions are being tested in trial NCT04003766?
The interventions under investigation include: biopsy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04003766?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.